Clinical Laboratory Tests Market Size, Share & Trends Report

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/ HCT testing), By End-Use (Primary Clinics, Central Laboratories), By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-361-4
  • Number of Pages: 104
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare
To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your research needs.

This website is secure and your personal details are safe.

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPA norms. All interactions are confidential.

  • GDPR.EU
  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

GVR Report cover Clinical Laboratory Tests Market Size, Share & Trends Report

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/ HCT testing), By End-Use (Primary Clinics, Central Laboratories), By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-361-4
  • Number of Pages: 104
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Clinical Laboratory Tests Market Trends

The global clinical laboratory tests market size was estimated at USD 114.63 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2030. The clinical laboratory tests market is witnessing growth due to factors such as the rising geriatric population, growing prevalence of target diseases, and introduction of innovative solutions to meet the growing demand of market for clinical lab testing. The increasing prevalence of diseases such as cardiovascular diseases and diabetes is expected to be a significant driver of market growth over the forecast period.

U.S. Clinical Laboratory Tests market size and growth rate, 2024 - 2030

According to the WHO, globally cardiovascular diseases cause approximately 17.9 million deaths each year, primarily due to heart disease and stroke as of 2021. Additionally, the prevalence of diabetes is constantly increasing, creating a substantial patient pool for the clinical laboratory test market. Drastic lifestyle changes, such as a growing number of smokers globally, rising obesity rates, and dietary irregularities, are major contributors to the high global prevalence of cardiovascular diseases. The added risk of developing cardiovascular conditions due to SARS-CoV-2 emphasizes the significant use of clinical laboratory tests for risk stratification. The increasing disease burden indicates market growth during the forecasted period.

According to WHO, life expectancy is now exceeding 80 years in most developed economies. Aging is influenced by the interaction of several environmental and genetic factors that affect immunity and metabolism, affecting the function of organs, and is characterized as a substantial risk factor for infectious disease development. The general purpose of clinical laboratory tests is to assist in identifying signs of nutrient deficiencies, detecting changes in health, evaluating bodily functions such as those of the kidney, liver, or thyroid, and monitoring the progression of treatment or disease. Thus, screening and diagnostics can play important role in the management of overall health. Thus, with an increase in the geriatric population, the need for acute and long-term healthcare is also rising, thereby driving the growth of market globally.

Moreover, introduction of innovative solutions for maximizing efficiency and minimizing errors is expected to serve this market as a high-impact rendering driver. Integrated workflow management systems, database management tools, and patient test records are gaining importance in healthcare industry with companies processing as many as 100 to 150 billion samples per year. Implementation and development of data management and informatics solutions for facilitating smooth operations are expected to drive the growth of this market. Additionally, technological innovation is expected to reduce the cost of tests in clinical medical laboratories.

However, the market growth is being restrained by the ambiguous regulatory framework associated with clinical laboratory tests. The healthcare industry is largely dependent upon regulatory frameworks established by organizations such as the U.S. FDA and EMA. There are no clear regulatory guidelines for diagnostic sector in developing countries such as China and India. The FDA has authority of regulation over laboratory-developed tests that refer to delivering efficient and rapid results and in-house clinical laboratories developing tests. Risks associated with LDTs may have a negative effect on profit margins and may lead to delays in commercialization of newly developed tests.

Market Concentration & Characteristics

The clinical laboratory tests market is in a high-growth stage, and the industry trends suggest that the pace of this growth is accelerating. It is characterized by a high degree of innovation driven by technological advancements and novel solutions. For instance, in February 2023, Hurdle announced the commercial availability of the Hemoglobin A1c (HbA1c) Test. This test enables adult consumers to take a simple at-home blood sample for diabetes screening and monitoring, showcasing ongoing innovation in testing methods and accessibility.

Clinical Laboratory Tests Market Concentration & Characteristics

The clinical laboratory tests market is also characterized by a high level of M&A activity by the leading players, reflecting strategic moves by key players. For instance, Cinven's involvement in the market signifies a proactive approach to capitalize on the industry's growth potential through acquisitions and partnerships.In May 2023, Cinven (SYNLAB) strengthened its regional presence and reinforced its leading position by investing in an advanced laboratory in Munich.

The clinical laboratory tests market is subject to increasing regulatory scrutiny. Regulatory bodies such as the U.S. FDA and EMA influence the industry, with potential negative effects on return margins and delays in commercialization. For instance, the FDA's authority over LDTs introduces risks and uncertainties. The FDA's oversight of LDTs implies that these tests need to meet certain regulatory standards to ensure efficiency, accuracy, and safety. The involvement of regulatory bodies introduces risks and uncertainties for companies operating in the clinical laboratory tests market. Adherence to regulatory guidelines and the potential need for adjustments to comply with evolving regulations can impact the financial aspects and timelines associated with bringing new tests to market.

There are a limited number of direct product substitutes for clinical laboratory tests. However, the launch of innovative tests such as OmegaQuant's HbA1c Test and LabCorp's LabCorp on demand demonstrates efforts to enhance testing methods, reducing the likelihood of substitutes.

The clinical laboratories test market sees a high degree of geographical expansion strategies, with key players such as Sonic Healthcare Limited and Fluxergy employing this approach to broaden their service reach. This strategy enhances service availability across diverse geographic areas, ensuring a more extensive presence in the industry.

Type Insights

There are various types of clinical laboratory tests such as HGB/ HCT testing, basic metabolic panel testing, BUN creatinine testing, electrolytes testing, HbA1c testing, comprehensive metabolic panel testing, liver panel testing, renal panel testing, lipid panel testing, and cardiovascular panel tests among others. HbA1c tests segment held the largest share of 12.29% in 2023. The rise in patient population with diabetes and cholesterol abnormalities is anticipated to propel segment growth as patients with fluctuations in HbA1c increase the risk of complications related to diabetes. Moreover, launch of newer laboratory tests is expected to further propel the market growth. For instance, in October 2023, Healthyr launched six at-home tests available at Walmart, making them the first to offer at-home dried blood spot tests in physical Walmart stores. The tests cover general health, cholesterol, HbA1c + glucose, thyroid, cholesterol and blood sugar, and STI. Such novel launches enable better access to a wide range of laboratory blood testing for evaluating sugar levels. In addition, in April 2023, FIND partnered with Abbott, i-SENS Inc, and Siemens Healthineers to enhance access to HbA1c testing for diabetes in low- and middle-income countries. The initiative aims to offer affordable point-of-care test kits, addressing limited access and improving diagnosis and management in these regions. Such initiatives by key players contribute to market expansion and growth during the forecasted period.

HGB/HCT tests segment is expected to show fastest growth rate over the forecast period.The growth of the segment is attributed to the occurrence of anemia and blood-related diseases among the population.The test is used to diagnose the presence of anemia or polycythemia. HGB/HCT test is also performed to monitor the drug responses and make decisions pertaining to blood transfusions or evaluation of dehydration. Increasing incidence rate of anemia & other blood disorders and introduction of noninvasive & technologically advanced products are expected to drive market growth during the forecast period.

End-use Insights

Central laboratories segment held the largest share of clinical laboratory tests market in 2023. The dominance of the segment is attributed to theprocedure volumes and high market penetration. An increasing number of initiatives carried out by government to provide various services, such as reimbursement for clinical laboratory tests, is another major factor anticipated to drive the market. Many healthcare institutions are working with laboratories to integrate different tests, such as microbiology testing. Moreover, large number of laboratories in emerging and underdeveloped economies can be accounted for a large share. Furthermore, regulatory authorities are undertaking initiatives to improve laboratory services and ease the process of diagnosis.

Global Clinical Laboratory Tests market share and size, 2023

Primary clinics segment is expected to show fastest growth over the forecast period. Primary clinics include standalone laboratories, laboratories in physician clinics & primary healthcare centers receiving samples directly from physicians, clinical research centers, and insurance companies. The test is made available to patients immediately with ease and the result is obtained quickly by care team, physician, and patients, enabling them to take clinical management decisions spontaneously. They provide a smaller test portfolio than hospital-based or standalone laboratories. These laboratories cater to the needs of a few specialties, and, hence, have a small share of revenue. Though these are smaller contributors, they are expected to make consistent contributions to market growth.

Regional Insights

North America held largest share of market in 2023 with a share of 48.8% and is expected to maintain its dominant position, in terms of share, throughout the forecast period. This can be attributed to the increasing geriatric population, rising prevalence of chronic diseases such as cancer, and high market penetration of technologically advanced diagnostic techniques are expected to drive market growth over the forecast period. According to the American Cancer Society, cancer is one of the leading causes of death in North America. The most commonly diagnosed cancers are prostate cancer in men and breast cancer in women. Increasing preference for novel approaches and rising patient awareness levels are also expected to drive the regional market. Moreover, key players are now focusing on improvised and software-enabled automated diagnostic systems that help in managing and processing hundreds of samples at a time and obtaining accurate results. Moreover, clinical laboratory tests save costs, lives, and time by enabling early detection and prevention of disease with U.S. performing more than 7 billion clinical lab tests per year.

Clinical Laboratory Tests Market Trends, by Region, 2024 - 2030

Asia Pacific is estimated to show the fastest growth in clinical laboratory tests market over the forecast period. The growth of the market in the region is due to the presence of huge untapped opportunities in the form of unmet medical needs, increasing avenues of scientific research, rising awareness about bleeding disorder testing, and positive economic growth. Asia Pacific region comprises over one-third of the global population and has been affected the most by the COVID-19 pandemic. Due to this, clinical laboratories have gained importance owing to their crucial role in conducting tests. China and India have conducted the highest number of tests for SARS-CoV-2. However, testing capacity needs to increase to fulfill the unmet needs in the clinical laboratory segment.

Key Companies & Market Share Insights

Some of the key players operating in the market include Quest Diagnostics Incorporated., Sonic Healthcare Limited, Laboratory Corporation of America Holdings. These key players are involved adopting various strategies for increasing their market share. New test launches, acquisitions, and partnerships are some of the common strategies utilized by these players to maintain their market dominance.

Clinical Reference Laboratory, Cinven are some of the emerging participants in the clinical laboratory tests market. The emerging players focus on introducing innovative and differentiating solutions. These companies are focusing on geographic expansion and customer acquisition strategies. Strategic partnerships, acquisitions, or collaborations are also some major strategies adopted by emerging players to enhance their capabilities and market presence

Key Clinical Laboratory Tests Companies:

  • Quest Diagnostics Incorporated.
  • Abbott
  • Cinven
  • Laboratory Corporation of America Holdings
  • ARUP Laboratories
  • OPKO Health, Inc.
  • UNILABS
  • Clinical Reference Laboratory, Inc.
  • Synnovis Group LLP
  • Sonic Healthcare Limited.

Recent Developments

  • In March 2023, Quest Diagnostics announced the launch of Post-COVID-19 Expanded Test Panel, which includes CBC, BMP, and Hepatic Function Panel.

  • In March 2023, Fluxergy announced the acquisition of InnaMed's Blood Testing Tech for the development of metabolic panel.

  • In February 2023, Detact Diagnostics, a Dutch biotech company, announced that it is setting up a new Keene State College (U.S.) laboratory with a 2-year rental contract.

  • In January 2023, QIAGEN released EZ2 Connect MDx, an in vitro diagnostics platform for automated sample processing for diagnostic laboratories. The device allows labs to purify RNA and DNA samples in 30 minutes.

Clinical Laboratory Tests Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 125.95 billion

Revenue forecast in 2030

USD 213.04 billion

Growth rate

CAGR of 9.2% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in (USD Billion) Volume (Number of Tests Conducted) and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Germany; U.K.; France; Italy; Spain; Denmark, Sweden, Norway, China; Japan; India; Australia; Thailand, South Korea; Brazil; Mexico, Argentina; South Africa; Saudi Arabia; UAE, Kuwait;

Key companies profiled

Quest Diagnostics Incorporated., Abbott, Cinven, Laboratory Corporation of America Holdings, ARUP Laboratories, OPKO Health, Inc., UNILABS, Clinical Reference Laboratory, Inc., Synnovis Group LLP, Sonic Healthcare Limited.

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

 

Global Clinical Laboratory Tests Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the clinical laboratory tests market on thetype, end-use, and region:

Global Clinical Laboratory Tests Market Report Segmentation

  • Type Outlook (Revenue, USD Billion, Numbers of Tests Conducted, 2018 - 2030)

    • Complete Blood Count

    • HGB/ HCT testing

    • Basic Metabolic Panel Testing

    • BUN Creatinine Testing

    • Electrolytes Testing

    • HbA1c Testing

    • Comprehensive Metabolic Panel Testing

    • Liver Panel Testing

      • Hepatitis

      • Bile Duct Obstruction

      • Liver Cirrhosis

      • Liver Cancer

      • Bone Disease

      • Autoimmune Disorders

      • Others

    • Renal Panel Testing

    • Lipid Panel Testing

    • Cardiovascular Panel Tests

  • End-use Outlook (Revenue, USD Billion, 2018 - 2030)

    • Central Laboratories

      • Complete Blood Count

      • HGB/ HCT testing

      • Basic Metabolic Panel Testing

      • BUN Creatinine Testing

      • Electrolytes Testing

      • HbA1c Testing

      • Comprehensive Metabolic Panel Testing

      • Liver Panel Testing

      • Renal Panel Testing

      • Lipid Panel Testing

      • Cardiovascular Panel Tests

    • Primary Clinics

      • Complete Blood Count

      • HGB/ HCT testing

      • Basic Metabolic Panel Testing

      • BUN Creatinine Testing

      • Electrolytes Testing

      • HbA1c Testing

      • Comprehensive Metabolic Panel Testing

      • Liver Panel Testing

      • Renal Panel Testing

      • Lipid Panel Testing

      • Cardiovascular Panel Tests

  • Regional Outlook (Revenue, USD Billion, Numbers of Tests Conducted, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

      • Rest of Europe

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Thailand

      • Rest of Asia Pacific

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Middle East and Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

      • Rest of Middle East and Africa

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Type
                        1.2.2. End-Use
                        1.2.3. Regional scope
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Type outlook
                        2.2.2. End-Use outlook
                        2.2.3. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Clinical Laboratory Tests Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing geriatric population
                            3.2.1.2. Growing prevalence of target disease
                            3.2.1.3. Introduction of innovative solutions
                        3.2.2. Market restraint analysis
                            3.2.2.1. Presence of ambiguous regulatory framework
                            3.2.2.2. COVID-19 pandemic
                    3.3. Clinical Laboratory Tests Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                    3.4. Pricing Analysis
Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis
                    4.1. Type Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Clinical Laboratory Tests Market by Type Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Complete Blood Count
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.2. HGB/HCT Testing
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.3. Basic Metabolic Panel Testing
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.4. BUN Creatinine Testing
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.5. Electrolytes Testing
                            4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.6. HbA1c Testing
                        4.4.7. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.8. Comprehensive Metabolic Panel Testing
                            4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.9. Liver Panel Testing
                            4.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                            4.4.9.2. Hepatitis
                                4.4.9.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                            4.4.9.3. Bile Duct Obstruction
                                4.4.9.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                            4.4.9.4. Liver Cirrhosis
                                4.4.9.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                            4.4.9.5. Liver Cancer
                                4.4.9.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                            4.4.9.6. Bone Disease
                                4.4.9.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                            4.4.9.7. Autoimmune Disorders
                                4.4.9.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                            4.4.9.8. Others
                                4.4.9.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                        4.4.10. Renal Panel Testing
                            4.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.11. Lipid Panel Testing
                            4.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        4.4.12. Cardiovascular Panel Testing
                            4.4.12.1. Market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
Chapter 5. Clinical Laboratory Tests Market: End-Use Estimates & Trend Analysis
                    5.1. End-Use Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global Clinical Laboratory Tests Market by End-Use Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.4.1. Central Laboratories
                            5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                        5.4.2. Primary Clinics
                            5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Share Analysis, 2023 & 2030
                    6.2. Regional Market Dashboard
                    6.3. Global Regional Market Snapshot
                    6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    6.5. North America
                        6.5.1. U.S.
                            6.5.1.1. Key country dynamics
                            6.5.1.2. Regulatory framework/ reimbursement structure
                            6.5.1.3. Competitive scenario
                            6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.5.2. Canada
                            6.5.2.1. Key country dynamics
                            6.5.2.2. Regulatory framework/ reimbursement structure
                            6.5.2.3. Competitive scenario
                            6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                    6.6. Europe
                        6.6.1. UK
                            6.6.1.1. Key country dynamics
                            6.6.1.2. Regulatory framework/ reimbursement structure
                            6.6.1.3. Competitive scenario
                            6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.6.2. Germany
                            6.6.2.1. Key country dynamics
                            6.6.2.2. Regulatory framework/ reimbursement structure
                            6.6.2.3. Competitive scenario
                            6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.6.3. France
                            6.6.3.1. Key country dynamics
                            6.6.3.2. Regulatory framework/ reimbursement structure
                            6.6.3.3. Competitive scenario
                            6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.6.4. Italy
                            6.6.4.1. Key country dynamics
                            6.6.4.2. Regulatory framework/ reimbursement structure
                            6.6.4.3. Competitive scenario
                            6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.6.5. Spain
                            6.6.5.1. Key country dynamics
                            6.6.5.2. Regulatory framework/ reimbursement structure
                            6.6.5.3. Competitive scenario
                            6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.6.6. Norway
                            6.6.6.1. Key country dynamics
                            6.6.6.2. Regulatory framework/ reimbursement structure
                            6.6.6.3. Competitive scenario
                            6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.6.7. Sweden
                            6.6.7.1. Key country dynamics
                            6.6.7.2. Regulatory framework/ reimbursement structure
                            6.6.7.3. Competitive scenario
                            6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.6.8. Denmark
                            6.6.8.1. Key country dynamics
                            6.6.8.2. Regulatory framework/ reimbursement structure
                            6.6.8.3. Competitive scenario
                            6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                    6.7. Asia Pacific
                        6.7.1. Japan
                            6.7.1.1. Key country dynamics
                            6.7.1.2. Regulatory framework/ reimbursement structure
                            6.7.1.3. Competitive scenario
                            6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.7.2. China
                            6.7.2.1. Key country dynamics
                            6.7.2.2. Regulatory framework/ reimbursement structure
                            6.7.2.3. Competitive scenario
                            6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.7.3. India
                            6.7.3.1. Key country dynamics
                            6.7.3.2. Regulatory framework/ reimbursement structure
                            6.7.3.3. Competitive scenario
                            6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.7.4. Australia
                            6.7.4.1. Key country dynamics
                            6.7.4.2. Regulatory framework/ reimbursement structure
                            6.7.4.3. Competitive scenario
                            6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.7.5. South Korea
                            6.7.5.1. Key country dynamics
                            6.7.5.2. Regulatory framework/ reimbursement structure
                            6.7.5.3. Competitive scenario
                            6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.7.6. Thailand
                            6.7.6.1. Key country dynamics
                            6.7.6.2. Regulatory framework/ reimbursement structure
                            6.7.6.3. Competitive scenario
                            6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                    6.8. Latin America
                        6.8.1. Brazil
                            6.8.1.1. Key country dynamics
                            6.8.1.2. Regulatory framework/ reimbursement structure
                            6.8.1.3. Competitive scenario
                            6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.8.2. Mexico
                            6.8.2.1. Key country dynamics
                            6.8.2.2. Regulatory framework/ reimbursement structure
                            6.8.2.3. Competitive scenario
                            6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.8.3. Argentina
                            6.8.3.1. Key country dynamics
                            6.8.3.2. Regulatory framework/ reimbursement structure
                            6.8.3.3. Competitive scenario
                            6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                    6.9. MEA
                        6.9.1. South Africa
                            6.9.1.1. Key country dynamics
                            6.9.1.2. Regulatory framework/ reimbursement structure
                            6.9.1.3. Competitive scenario
                            6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.9.2. Saudi Arabia
                            6.9.2.1. Key country dynamics
                            6.9.2.2. Regulatory framework/ reimbursement structure
                            6.9.2.3. Competitive scenario
                            6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.9.3. UAE
                            6.9.3.1. Key country dynamics
                            6.9.3.2. Regulatory framework/ reimbursement structure
                            6.9.3.3. Competitive scenario
                            6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
                        6.9.4. Kuwait
                            6.9.4.1. Key country dynamics
                            6.9.4.2. Regulatory framework/ reimbursement structure
                            6.9.4.3. Competitive scenario
                            6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                        7.3.4. Abbott
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. CINVEN
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. QUEST DIAGNOSTICS INCORPORATED
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. OPKO HEALTH, INC.
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. F. Laboratory Corporation of America Holdings
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. UNILABS
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. Synnovis Group LLP
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. SONIC HEALTHCARE
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                            7.3.11.5. Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 North America clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
Table 3 North America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 4 North America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 5 U.S. clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 6 U.S. clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 7 Canada clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 8 Canada clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 9 Europe clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
Table 10 Europe clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 11 Europe clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 12 Germany clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 13 Germany clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 14 UK clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 15 UK clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 16 France clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 17 France clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 18 Italy clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 19 Italy clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 20 Spain clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 21 Spain clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 22 Denmark clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 23 Denmark clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 24 Sweden clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 25 Sweden clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 26 Norway clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 27 Norway clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 28 Asia Pacific clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
Table 29 Asia Pacific clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 30 Asia Pacific clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 31 China clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 32 China clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 33 Japan clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 34 Japan clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 35 India clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 36 India clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 37 South Korea clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 38 South Korea clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 39 Australia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 40 Australia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 41 Thailand clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 42 Thailand clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 43 Latin America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 44 Latin America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 45 Brazil clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 46 Brazil clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 47 Mexico clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 48 Mexico clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 49 Argentina clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 50 Argentina clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 51 MEA clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
Table 52 MEA clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 53 MEA clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 54 South Africa clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 55 South Africa clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 56 Saudi Arabia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 57 Saudi Arabia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 58 UAE clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 59 UAE clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
Table 60 Kuwait clinical laboratory tests market, by type, 2018 - 2030 (USD Billion) (Numbers of Tests Conducted)
Table 61 Kuwait clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Clinical laboratory tests market: market outlook
Fig. 14 Clinical laboratory tests competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Clinical laboratory tests market driver impact
Fig. 20 Clinical laboratory tests market restraint impact
Fig. 21 Clinical laboratory tests market strategic initiatives analysis
Fig. 22 Clinical laboratory tests market: Type movement analysis
Fig. 23 Clinical laboratory tests market: Type outlook and key takeaways
Fig. 24 CBC market estimates and forecast, 2018 - 2030
Fig. 25 HGB/HCT test market estimates and forecast, 2018 - 2030
Fig. 26 Basic metabolic panel market estimates and forecast, 2018 - 2030
Fig. 27 BUN creatinine test market estimates and forecast, 2018 - 2030
Fig. 28 Electrolyte tests market estimates and forecast, 2018 - 2030
Fig. 29 HbA1c tests market estimates and forecast, 2018 - 2030
Fig. 30 Comprehensive metabolic panel market estimates and forecast, 2018 - 2030
Fig. 31 Liver panel test market estimates and forecast, 2018 - 2030
Fig. 32 Hepatitis liver panel tests market estimates and forecast, 2018 - 2030
Fig. 33 Bile duct obstruction liver panel tests market estimates and forecast, 2018 - 2030
Fig. 34 Liver cirrhosis liver panel tests market estimates and forecast, 2018 - 2030
Fig. 35 Liver cancer liver panel tests market estimates and forecast, 2018 - 2030
Fig. 36 Bone disease liver panel tests market estimates and forecast, 2018 - 2030
Fig. 37 Autoimmune disorders liver panel tests market estimates and forecast, 2018 - 2030
Fig. 38 Others liver panel tests market estimates and forecast, 2018 - 2030
Fig. 39 Renal panel test market estimates and forecast, 2018 - 2030
Fig. 40 Lipid panel tests market estimates and forecast, 2018 - 2030
Fig. 41 Cardiovascular panel test market estimates and forecast, 2018 - 2030
Fig. 42 Clinical laboratory tests market: End-Use movement Analysis
Fig. 43 Clinical laboratory tests market: End-Use outlook and key takeaways
Fig. 44 Central Laboratories market estimates and forecasts, 2018 - 2030
Fig. 45 Primary Clinics market estimates and forecasts,2018 - 2030
Fig. 46 Global clinical laboratory tests market: Regional movement analysis
Fig. 47 Global clinical laboratory tests market: Regional outlook and key takeaways
Fig. 48 Global clinical laboratory tests market share and leading players
Fig. 49 North America market share and leading players
Fig. 50 Europe market share and leading players
Fig. 51 Asia Pacific market share and leading players
Fig. 52 Latin America market share and leading players
Fig. 53 Middle East & Africa market share and leading players
Fig. 54 North America: SWOT
Fig. 55 Europe SWOT
Fig. 56 Asia Pacific SWOT
Fig. 57 Latin America SWOT
Fig. 58 MEA SWOT
Fig. 59 North America, by country
Fig. 60 North America
Fig. 61 North America market estimates and forecasts, 2018 - 2030
Fig. 62 U.S.
Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
Fig. 64 Canada
Fig. 65 Canada market estimates and forecasts, 2018 - 2030
Fig. 66 Europe
Fig. 67 Europe market estimates and forecasts, 2018 - 2030
Fig. 68 UK
Fig. 69 UK market estimates and forecasts, 2018 - 2030
Fig. 70 Germany
Fig. 71 Germany market estimates and forecasts, 2018 - 2030
Fig. 72 France
Fig. 73 France market estimates and forecasts, 2018 - 2030
Fig. 74 Italy
Fig. 75 Italy market estimates and forecasts, 2018 - 2030
Fig. 76 Spain
Fig. 77 Spain market estimates and forecasts, 2018 - 2030
Fig. 78 Denmark
Fig. 79 Denmark market estimates and forecasts, 2018 - 2030
Fig. 80 Sweden
Fig. 81 Sweden market estimates and forecasts, 2018 - 2030
Fig. 82 Norway
Fig. 83 Norway market estimates and forecasts, 2018 - 2030
Fig. 84 Asia Pacific
Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 86 China
Fig. 87 China market estimates and forecasts, 2018 - 2030
Fig. 88 Japan
Fig. 89 Japan market estimates and forecasts, 2018 - 2030
Fig. 90 India
Fig. 91 India market estimates and forecasts, 2018 - 2030
Fig. 92 Thailand
Fig. 93 Thailand market estimates and forecasts, 2018 - 2030
Fig. 94 South Korea
Fig. 95 South Korea market estimates and forecasts, 2018 - 2030
Fig. 96 Australia
Fig. 97 Australia market estimates and forecasts, 2018 - 2030
Fig. 98 Latin America
Fig. 99 Latin America market estimates and forecasts, 2018 - 2030
Fig. 100 Brazil
Fig. 101 Brazil market estimates and forecasts, 2018 - 2030
Fig. 102 Mexico
Fig. 103 Mexico market estimates and forecasts, 2018 - 2030
Fig. 104 Argentina
Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
Fig. 106 Middle East and Africa
Fig. 107 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 108 South Africa
Fig. 109 South Africa market estimates and forecasts, 2018 - 2030
Fig. 110 Saudi Arabia
Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 112 UAE
Fig. 113 UAE market estimates and forecasts, 2018 - 2030
Fig. 114 Kuwait
Fig. 115 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 116 Market share of key market players- Clinical

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
    • Complete Blood Count
    • HGB/ HCT Testing
    • Basic Metabolic Panel Testing
    • BUN Creatinine Testing
    • Electrolytes Testing
    • HbA1c Testing
    • Comprehensive Metabolic Panel Testing
    • Liver Panel Testing
      • Hepatitis
      • Bile Duct Obstruction
      • Liver Cirrhosis
      • Liver Cancer
      • Bone Disease
      • Autoimmune Disorders
      • Others
    • Renal Panel Testing
    • Lipid Panel Testing
    • Cardiovascular Panel Tests
  • End-Use Outlook (Revenue in USD Billion, 2018 - 2030)
    • Central Laboratories
      • Complete Blood Count
      • HGB/ HCT testing
      • Basic Metabolic Panel Testing
      • BUN Creatinine Testing
      • Electrolytes Testing
      • HbA1c Testing
      • Comprehensive Metabolic Panel Testing
      • Liver Panel Testing
      • Renal Panel Testing
      • Lipid Panel Testing
      • Cardiovascular Panel Tests
    • Primary Clinics
      • Complete Blood Count
      • HGB/ HCT testing
      • Basic Metabolic Panel Testing
      • BUN Creatinine Testing
      • Electrolytes Testing
      • HbA1c Testing
      • Comprehensive Metabolic Panel Testing
      • Liver Panel Testing
      • Renal Panel Testing
      • Lipid Panel Testing
      • Cardiovascular Panel Tests
  • Regional Outlook (Revenue, USD Billion, 2018- 2030)
    • North America
      • North America Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
        • Complete Blood Count
        • HGB/ HCT Testing
        • Basic Metabolic Panel Testing
        • BUN Creatinine Testing
        • Electrolytes Testing
        • HbA1c Testing
        • Comprehensive Metabolic Panel Testing
        • Liver Panel Testing
          • Hepatitis
          • Bile Duct Obstruction
          • Liver Cirrhosis
          • Liver Cancer
          • Bone Disease
          • Autoimmune Disorders
          • Others
        • Renal Panel Testing
        • Lipid Panel Testing
        • Cardiovascular Panel Tests
      • North America Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)
        • Central Laboratories
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • U.S.
        • U.S. Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • U.S. Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Canada
        • Canada Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Canada Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
    • Europe
      • Europe Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
        • Complete Blood Count
        • HGB/ HCT Testing
        • Basic Metabolic Panel Testing
        • BUN Creatinine Testing
        • Electrolytes Testing
        • HbA1c Testing
        • Comprehensive Metabolic Panel Testing
        • Liver Panel Testing
          • Hepatitis
          • Bile Duct Obstruction
          • Liver Cirrhosis
          • Liver Cancer
          • Bone Disease
          • Autoimmune Disorders
          • Others
        • Renal Panel Testing
        • Lipid Panel Testing
        • Cardiovascular Panel Tests
      • Europe Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)
        • Central Laboratories
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Primary Clinics
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
      • U.K.
        • UK Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • UK Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Germany
        • Germany Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Germany Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • France
        • France Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • France Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Italy
        • Italy Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Italy Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Spain
        • Spain Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Spain Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Denmark
        • Denmark Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Denmark Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Sweden
        • Sweden Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Sweden Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Norway
        • Norway Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Norway Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
    • Asia Pacific
      • Asia Pacific Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
        • Complete Blood Count
        • HGB/ HCT Testing
        • Basic Metabolic Panel Testing
        • BUN Creatinine Testing
        • Electrolytes Testing
        • HbA1c Testing
        • Comprehensive Metabolic Panel Testing
        • Liver Panel Testing
          • Hepatitis
          • Bile Duct Obstruction
          • Liver Cirrhosis
          • Liver Cancer
          • Bone Disease
          • Autoimmune Disorders
            • Others
        • Renal Panel Testing
        • Lipid Panel Testing
        • Cardiovascular Panel Tests
      • Asia Pacific Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
        • Central Laboratories
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Primary Clinics
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
      • Japan
        • Japan Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Japan Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • China
        • China Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • China Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • India
        • India Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • India Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Australia
        • Australia Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Australia Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Thailand
        • Thailand Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Thailand Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • South Korea
        • South Korea Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • South Korea Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
    • Latin America
      • Latin America Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
        • Complete Blood Count
        • HGB/ HCT Testing
        • Basic Metabolic Panel Testing
        • BUN Creatinine Testing
        • Electrolytes Testing
        • HbA1c Testing
        • Comprehensive Metabolic Panel Testing
        • Liver Panel Testing
          • Hepatitis
          • Bile Duct Obstruction
          • Liver Cirrhosis
          • Liver Cancer
          • Bone Disease
          • Autoimmune Disorders
          • Others
        • Renal Panel Testing
        • Lipid Panel Testing
        • Cardiovascular Panel Tests
      • Latin America Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
        • Central Laboratories
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Primary Clinics
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
      • Brazil
        • Brazil Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Brazil Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Mexico
        • Mexico Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Mexico Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Argentina
        • Argentina Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Argentina Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
    • MEA
      • MEA Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
        • Complete Blood Count
        • HGB/ HCT Testing
        • Basic Metabolic Panel Testing
        • BUN Creatinine Testing
        • Electrolytes Testing
        • HbA1c Testing
        • Comprehensive Metabolic Panel Testing
        • Liver Panel Testing
          • Hepatitis
          • Bile Duct Obstruction
          • Liver Cirrhosis
          • Liver Cancer
          • Bone Disease
          • Autoimmune Disorders
          • Others
        • Renal Panel Testing
        • Lipid Panel Testing
        • Cardiovascular Panel Tests
      • MEA Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
        • Central Laboratories
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Primary Clinics
          • Complete Blood Count
          • HGB/ HCT testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
      • South Africa
        • South Africa Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • South Africa Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Saudi Arabia
        • Saudi Arabia Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Saudi Arabia Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
          • Cardiovascular Panel Tests
      • UAE
        • UAE Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • UAE Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
      • Kuwait
        • Kuwait Market: Type Outlook (Revenue in USD Billion, Numbers of Tests Conducted, 2018 - 2030)
          • Complete Blood Count
          • HGB/ HCT Testing
          • Basic Metabolic Panel Testing
          • BUN Creatinine Testing
          • Electrolytes Testing
          • HbA1c Testing
          • Comprehensive Metabolic Panel Testing
          • Liver Panel Testing
            • Hepatitis
            • Bile Duct Obstruction
            • Liver Cirrhosis
            • Liver Cancer
            • Bone Disease
            • Autoimmune Disorders
            • Others
          • Renal Panel Testing
          • Lipid Panel Testing
          • Cardiovascular Panel Tests
        • Kuwait Market: End-Use Outlook (Revenue in USD Billion, 2018 - 2030)  Central Laboratories
          • Central Laboratories
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests
          • Primary Clinics
            • Complete Blood Count
            • HGB/ HCT testing
            • Basic Metabolic Panel Testing
            • BUN Creatinine Testing
            • Electrolytes Testing
            • HbA1c Testing
            • Comprehensive Metabolic Panel Testing
            • Liver Panel Testing
            • Renal Panel Testing
            • Lipid Panel Testing
            • Cardiovascular Panel Tests

Clinical Laboratory Tests Market Dynamics

Driver: Increasing Geriatric Population

The global geriatric population is increasing. According to 2020 UN estimates, there were around 727 million people aged 65 and above globally. In addition, the number of individuals aged 80 and above is projected to double to over 1.5 billion by 2050. Aging has become a substantial risk factor for numerous diseases, including diabetes & obesity, which increase the risk of diseases and lead to metabolic imbalances. This is projected to fuel the demand for clinical laboratory tests. According to WHO, life expectancy is now exceeding 80 years in most developed economies. Aging is influenced by the interaction of several environmental and genetic factors that impact immunity & metabolism, affecting the function of organs, and is characterized as a substantial risk for infectious disease development. Disease screening and diagnosis can play an important role in the management of overall health. Thus, with an increase in the geriatric population, the need for acute and long-term healthcare is also rising, thereby driving the growth of the clinical laboratory tests market globally.

Driver: Growing Prevalence of Target Disease

An increase in disease prevalence and high demand for early disease diagnosis are expected to boost the market in the coming years. These factors have prompted market players to introduce innovative tests to address the growing demand. The introduction of accurate and technologically advanced products, such as biochips, microarrays, and companion diagnostics, has increased the demand for early disease detection. This is mainly due to a rising healthcare expenditure owing to an increasing prevalence of chronic diseases. For instance, biochips are used for making 1000s of RNA, DNA, or protein samples, which can be processed simultaneously on a single chip. Products, such as companion diagnostics, also reduce the overall healthcare cost by helping physicians identify the most suitable treatment option based on the genetic makeup of a patient. Furthermore, the growing prevalence of target diseases, such as cardiovascular diseases and diabetes, is expected to be a high-impact rendering driver of the market.

Restraint: Presence of Ambiguous Regulatory Framework

The regulatory framework for approvals has always posed major restraints on the growth rate of the pharmaceutical, biotechnology, and medical technology industries. Globally, usage & safety profiles of laboratory tests are highly variable and evaluated by health regulatory agencies of each country differently. This makes the approval of novel products slower. Approval decisions for novel products vary from nation to nation based on case, which may hinder market growth. However, the regulatory landscape is changing, and countries, such as Mexico, make entry of products already approved in the U.S. or Europe easier. Unclear regulatory frameworks/guidelines for diagnostics in developing economies are anticipated to restrain market growth. The availability of such discrete and uncertain scenarios in regulations for molecular diagnostic products can create confusion among manufacturers regarding commercialization. However, many initiatives are being taken globally to enhance the acceptability and adoption of clinical laboratory tests & solutions, along with a developed regulatory scenario.

What Does This Report Include?

This section will provide insights into the contents included in this clinical laboratory tests market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Clinical laboratory tests market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Clinical laboratory tests market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the clinical laboratory tests market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for clinical laboratory tests market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of clinical laboratory tests market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Clinical Laboratory Tests Market Categorization:

The clinical laboratory tests market was categorized into three segments, namely type (Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Cardiovascular Panel Tests), end-use (Central Laboratories, Primary Clinics), and region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa)

Segment Market Methodology:

The clinical laboratory tests market was segmented into type, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The clinical laboratory tests market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark, Sweden, Norway, China; Japan; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Clinical laboratory tests market companies & financials:

The clinical laboratory tests market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Abbott - Abbott is a healthcare company with five core business segments: pharmaceuticals, medical devices, nutrition, vascular care, and diagnostics. The company is present in more than 150 countries. In October 2011, Abbott Laboratories announced its decision to divide into two companies-one focused on research-based pharmaceuticals and the other on diversified medical products. In September 2017, it acquired Alere, Inc. to expand its diagnostics business.

  • Laboratory Corporation of America Holdings - Laboratory Corporation of America Holdings (LabCorp) is engaged in the development of genetic test solutions based on microarray, NGS, and PCR technology. The company serves more than 220,000 clients in 60 countries. Its clients are hospitals, physicians, employers, governmental agencies, and other independent clinical laboratories. Its diagnostic business segment offers gene-based tests for HIV drug-resistance assays, HPV, and molecular genetic testing for cystic fibrosis. It provides over 4,700 tests in the areas of diagnostic genetics, allergy, cardiovascular diseases, coagulation, women's health, oncology, endocrinology, infectious diseases, pain management, toxicology, and pharmacogenetics.

  • Opko Health, Inc. - Opko Health, Inc. is a healthcare company that established itself in large and growing markets. The company’s diagnostics business refers to Bio-Reference Laboratories, a clinical lab with a genetic testing ability that includes the 4Kscore, a prostate cancer screening test, and the Claros1 immunoassay testing platform. The company focuses on novel molecular diagnostics, point-of-care, vaccines, and proprietary pharmaceuticals. In August 2015, it acquired Bio-Reference Laboratories.

  • Synnovis Group LLP (Viapath Group LLP) - Viapath Group LLP is a partnership company. The majority of the company is owned by the NHS; however, it has the freedom to invest for growth. It operates in the following segments: Specialist Reference Testing, Pathology, Diagnostics, Genetics, NHS, Virology, Biochemistry, Research & Development, Innovation, Immunology, Virology, Biochemistry, Histology, Clinical Transplantation, Phlebotomy, Toxicology, Cellular Pathology, Blood Sciences, Cancer Testing, Infection Sciences, and Learning & Development.

  • Sonic Healthcare - Sonic Healthcare provides radiology & laboratory pathology services and follows a federation model, with largely decentralized operations. The company is divided into a decentralized federation of medically led practices. The company employs around 800 specialist pathologists, over 200 radiologists, and others as general practitioners & medical scientists with technicians.

  • Cinven - Cinven is an international, private company that operates in seven sectors: industrials, technology, media & telecommunications, business services, consumer, healthcare, and financial services.

  • Quest Diagnostics - The company has administrative offices in Lyndhurst, Collegeville, and Pennsylvania. In 2013, Fortune magazine ranked the company at apex position in pharmacy and other services. The company conducts over 150 million tests each year.

  • ARUP Laboratories - The company serves as the national reference for the U.S. It provides about 3,000 tests and their combinations encompassing various fields of clinical medicine, such as clinical chemistry, cytogenetics, immunology, molecular genetics, endocrinology, obstetrics, neonatology, neurology, pediatrics, oncology, hematology, anatomic pathology, & infectious diseases.

  • UNILABS - Unilabs is one of the leading laboratories in Europe to provide diagnostic services. The company offers pathology, imaging, and laboratory tests. Its services include laboratory medicine, cellular pathology, medical imaging, specialty testing, drug development services, reproductive medicine, and genetics.

  • Clinical Reference Laboratory - The key services include molecular diagnostic testing & clinical trials, as well as urine, oral fluid, and blood testing for patients, employers, healthcare providers, & health insurance industries.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Clinical Laboratory Tests Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Clinical Laboratory Tests Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.